In a regulatory filing, Quanterix (QTRX) disclosed that its director William Donnely bought 93.1K shares of common stock on June 6th in a total transaction size of $506K.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QTRX:
- Akoya Biosciences price target lowered to $1.14 from $3 at Morgan Stanley
- Hold Rating on Quanterix Amid Merger Uncertainties and Economic Pressures
- Akoya Biosciences price target lowered to $1.08 from $1.80 at Canaccord
- Quanterix’s Earnings Call: Resilience Amid Challenges
- Quanterix Faces Revenue Challenges Amid Project Delays and Tariff Impacts, Holds Rating Due to Cautious Outlook